Ribba, A.S., Hilber, L., Lavergne, J.M., Fressinaud, E., Boyer-Neumann, C., Ternicien, C., et al. (2001) The Arginine-552-CYSTEINE (R1315C) Mutation within the AJ Loop of Von Willebrand Factor Induces an Abnormal Folding with a Loss Function Resulting in Type 2A Like Phenotype of von Willebrand Disease: Study of 10 Patients and Mutated Recombinant von Willebrand Factor. Blood, 97, 952-959.
https://doi.org/10.1182/blood.V97.4.952

has been cited by the following article:

• TITLE: First Case of Von Willebrand Disease in Niger

  AUTHORS: Amadou Djibrilla-Almoustapha, Moustapha Maman-Brah, Moustapha Elhadji-Chefou, Maman Rabiou Badé, Amal Al-Azhari, Youssoufa Seydou-Moussa, Maman Aminou Mahamane Sani, Mamane Daou, Souleymane Brah, Badé Malam-Abdou

  KEYWORDS: Willebrand Disease, Onco, Hematology, Niamey, Niger

  JOURNAL NAME: Open Journal of Blood Diseases, Vol.11 No.1, January 21, 2021

  ABSTRACT: Von Willebrand’s disease was first described in 1926 by Erik Von Willebrand. It is a genetic, constitutional defect of hemostasis that is different from hemophilia. It is classified among the rare diseases whose clinical manifestations are dominated by a hemorrhagic profile, which varies from patient to patient. It is an easily diagnosed disease based on a quantitative and qualitative bioassay of VWF. Treatment is multidisciplinary and is based on well-structured prevention. We report the first case of von Willebrand disease in Niger, diagnosed in the Hematology Department of Niamey’s National Hospital.